{"id":652,"date":"2022-01-19T11:16:26","date_gmt":"2022-01-19T11:16:26","guid":{"rendered":"https:\/\/avaeh.org\/web_nueva_2021\/?p=652"},"modified":"2022-01-19T11:16:28","modified_gmt":"2022-01-19T11:16:28","slug":"ensayo-fase-2-farmaco-tominersen-para-eh","status":"publish","type":"post","link":"https:\/\/avaeh.org\/web_nueva_2021\/2022\/01\/19\/ensayo-fase-2-farmaco-tominersen-para-eh\/","title":{"rendered":"Ensayo Fase 2 f\u00e1rmaco Tominersen para EH"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Nuevo Ensayo para Enfermedad de Huntington. Ionis Pharma ha publicado un comunicado para informar sobre un nuevo ensayo de fase 2 con el f\u00e1rmaco Tominersen. Con los datos obtenidos del Generation HD, se ha observado indicios de cambios entre el sector de adultos j\u00f3venes con menor afectaci\u00f3n de la enfermedad, es por ello que se va proceder a investigar m\u00e1s en base a estos resultados.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Link al comunicado en pdf:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/ir.ionispharma.com\/news-releases\/news-release-details\/ionis-partner-evaluate-tominersen-huntingtons-disease-new-phase\">https:\/\/ir.ionispharma.com\/news-releases\/news-release-details\/ionis-partner-evaluate-tominersen-huntingtons-disease-new-phase<\/a><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"509\" src=\"https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/01\/ionis.jpg\" alt=\"\" class=\"wp-image-653\" srcset=\"https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/01\/ionis.jpg 720w, https:\/\/avaeh.org\/web_nueva_2021\/wp-content\/uploads\/2022\/01\/ionis-300x212.jpg 300w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Nuevo Ensayo para Enfermedad de Huntington. Ionis Pharma ha publicado un comunicado para informar sobre un nuevo ensayo de fase 2 con el f\u00e1rmaco Tominersen. Con los datos obtenidos del Generation HD, se ha observado indicios de cambios entre el sector de adultos j\u00f3venes con menor afectaci\u00f3n de la enfermedad, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":653,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7,6,4,9,76,78,5,74,58,8,77,75],"class_list":["post-652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria","tag-asociacion-valenciana-de-enfermedad-de-huntington","tag-avaeh","tag-enfermedad-de-huntington","tag-enfermedades-raras","tag-ensayo-fase-ii","tag-generation-hd","tag-huntingtons-disease","tag-ionis-pharma","tag-neurodegenerativa","tag-rare-diseases","tag-roche","tag-tominersen"],"_links":{"self":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/comments?post=652"}],"version-history":[{"count":1,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/652\/revisions"}],"predecessor-version":[{"id":654,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/652\/revisions\/654"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media\/653"}],"wp:attachment":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media?parent=652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/categories?post=652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/tags?post=652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}